Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Expert commentary on the use of PARP inhibitors as frontline maintenance therapy in the treatment of ovarian cancer, from Clinical Care Options
In this slideset, CCO’s expert faculty explores the role of biomarkers and HRD when treating patients with ovarian cancer using PARP inhibitors
CCO’s expert faculty reviews PARP inhibitors in the treatment of patients with recurrent ovarian cancer.
CCO’s expert faculty reviews the different PARP inhibitors in the treatment of patients with newly diagnosed ovarian cancer.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.